6,000
Participants
Start Date
January 31, 2014
Primary Completion Date
February 29, 2020
Study Completion Date
March 31, 2021
Implantable loop recorder (Medtronic Reveal LINQ(TM))
The patients in the experimental arm receive an implantable loop recorder (Medtronic Reveal LINQ(TM)) with continuous monitoring, and are followed by daily automated remote transmissions. New arrhythmia episodes are reviewed daily by an experienced medical doctor. If AF lasting ≥6 minutes is detected and confirmed by at least two senior cardiologists, OAC is initiated. Decision about specific type of OAC, and possible further clinical work-up or treatment, is left to the treating physician and the patient. The remote monitoring continues until end of service of the device, patient withdrawal or other end-of-study.
Rigshospitalet, Copenhagen
Bispebjerg Hospital
OTHER
Zealand University Hospital
OTHER
Odense University Hospital
OTHER
University of Southern Denmark
OTHER
Aalborg University
OTHER
Rigshospitalet, Denmark
OTHER